Bioorganic & Medicinal Chemistry
基本信息
The Tetrahedron Journal for Research at the Interface of Chemistry and Biology Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. The Journal welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets the reporting of the discovery, design or optimization of potent new compounds or biological agents the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data the reporting of "first-in-class" new therapeutic compounds the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism methodological advances that are chemistry-based and which significantly impact on medicine or biology the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states the development of materials for specific therapeutic targeting All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
CiteScore
| 学科 | 排名 | 百分位 |
|---|---|---|
Pharmacology, Toxicology and PharmaceuticsPharmaceutical Science |
45 / 183 | 75% |
期刊统计
投稿信息
投稿网址:
https://www.editorialmanager.com/BMCHEM收录体裁:
Reviews
Perspectives
Symposia-in-Prin
相关文献
Carbon material-supported Fe7C3@FeO nanoparticles: a highly efficient catalyst for carbon dioxide reduction with 1-butene
Bing Yan, Luyi Wang, Bolong Wang, Quanxin Chen, Chunjing Liu, Jian Li, Tao Jiang
DOI: 10.1039/D0RE00249F
Unsaturated poly(phosphoester)s via ring-opening metathesis polymerization
Evandro M. Alexandrino, Frederik R. Wurm
DOI: 10.1039/C3PY00437F
Integrated multi-step continuous flow synthesis of daclatasvir without intermediate purification and solvent exchange
Subhash Ghosh
DOI: 10.1039/D0RE00323A
Solvent-free manufacture of methacrylate polymers from biomass pyrolysis products
J. Ryan, M. T. Elsmore, E. R. Binner, D. S. A. De Focatiis, D. J. Irvine, J. P. Robinson
DOI: 10.1039/D0RE00419G
Linkage and acceptor effects on diverse memory behavior of triphenylamine-based aromatic polymers
Chih-Jung Chen, Yi-Cheng Hu, Guey-Sheng Liou
DOI: 10.1039/C3PY00500C
Single chain polymernanoparticlesvia sequential ATRP and oxidative polymerization
Philip T. Dirlam, Hyo Ju Kim, Kyle J. Arrington, Woo Jin Chung, Rabindra Sahoo, Lawrence J. Hill, Philip J. Costanzo, Patrick Theato, Kookheon Char
DOI: 10.1039/C3PY00321C
Cross-linkable aggregation induced emission dye based red fluorescent organic nanoparticles and their cell imaging applications
Xiqi Zhang, Meiying Liu, Bin Yang, Xiaoyong Zhang, Zhenguo Chi, Siwei Liu, Jiarui Xu, Yen Wei
DOI: 10.1039/C3PY00860F
Improvement of n-butanol Guerbet condensation: a reaction integration of n-butanol Guerbet condensation and 1,1-dibutoxybutane hydrolysis
Xiaoxu Han, Shuaiqi Li, Hualiang An, Xinqiang Zhao, Yanji Wang
DOI: 10.1039/D1RE00206F
Conjugated poly(azomethine)s via simple one-step polycondensation chemistry: synthesis, thermal and optoelectronic properties
Ricardo K. M. Bouwer, Ugo Lafont, René J. P. Kist, Marcus L. Böhm, Tom J. Savenije, Laurens D. A. Siebbeles, Neil C. Greenham, Theo J. Dingemans
DOI: 10.1039/C3PY00433C
您可能还喜欢
4-[4-三氟甲基苯基]恶唑(CAS号:1126636-40-5)通常如何合成?
4-[4-三氟甲基苯基]恶唑通常通过将4-三氟甲基苯酚与异硫氰酸苯酯在有机溶剂中进行酯化反应合成。该反应可在无水条件下,使用适当的催化剂,如四丁基氢氧化铵,以提...
RockPhos Pd G3(CAS号:2009020-38-4)通常如何合成?
RockPhos Pd G3 通常通过钯催化偶联反应合成,使用配体 (2'-Amino-2-biphenylyl)(methanesulfonato-kappa...
1-哌啶甲酰胺(CAS号:2158-03-4)的市场或研究趋势如何?
1-哌啶甲酰胺作为有机合成中的重要中间体,其市场需求主要受医药、农药、染料等行业推动。近年来,随着新药开发和绿色化学的发展,该化合物的研究趋势集中在开发更高效、...
2-(二苯基膦基)乙胺(CAS号:4848-43-5)适用哪些法规指南?
2-(二苯基膦基)乙胺适用于多种法规指南,包括但不限于《全球化学品统一分类和标签制度》(GHS),欧盟《化学品注册、评估、授权和限制》法规(REACH),以及美...
如何储存间苯二甲酸二烯丙酯(CAS号:1087-21-4)?
间苯二甲酸二烯丙酯应储存在阴凉、干燥、通风良好的地方,远离火源和热源。储存容器应密封,避免光照和高温。储存温度应控制在25℃以下,相对湿度应低于80%。避免与其...
什么是间甲苯异硫代异氰酸酯(CAS号:621-30-7)?
间甲苯异硫代异氰酸酯是一种有机化合物,分子式为C7H7NO2S,具有刺激性气味。它是一种重要的有机合成中间体,在合成其他化合物时广泛应用。
在合成中是否有N-Boc-D-苯丙氨醇(CAS号:106454-69-7)的替代品?
在合成中,可以考虑使用N-Cbz-D-苯丙氨醇或N-Fmoc-D-苯丙氨醇作为替代品。这些化合物同样具有保护氨基的功能,且在合成过程中表现出良好的反应性能。
3-羟甲基-2-氧异丙基吡啶(CAS号:954240-50-7)的主要用途是什么?
3-羟甲基-2-氧异丙基吡啶主要用于有机合成领域,可以作为合成其他药物、农药或精细化学品的中间体。此外,它还可能在实验室研究中作为特定反应的前体或溶剂。
6-氨基-9-甲基嘌呤(CAS号:700-00-5)应用于哪些行业?
6-氨基-9-甲基嘌呤目前主要应用于医药行业,作为某些药物的中间体。此外,它还可能用于聚合物、传感器和半导体的某些领域,作为功能性单体或掺杂剂。

















![(4-{[(2-Methyl-2-propanyl)oxy]methyl}phenyl)boronic acid structure (4-{[(2-Methyl-2-propanyl)oxy]methyl}phenyl)boronic acid structure](https://cnstatic.chemtradehub.com/structs/102/1024017-53-5-41c0.webp)